Fate Therapeutics

Skip to content

About Us
Pipeline
- Overview
- Immuno-Oncology Candidates
  - NK100
  - FT500
  - FT516
  - FT596
  - FT538
  - FT819
- Immuno-Regulation Candidates
  - ProTmune^™
  - FT301
Science
Collaborations
Join Our Team
Investors
Contact

One Cell. Many Fates.

for immuno-oncology

[CD34⁺]

for immuno-regulation

[T-Cell, NK Cell]

Transforming the lives of patients with cancer and immune disorders

NK100
FT500
FT516
FT596
FT538
FT819
ProTmune^™
FT301
Press Releases

©2020 Fate Therapeutics | 3535 General Atomics Court, Suite 200, San Diego 92121 | 866.875.1833 | LEGAL

About Us
Pipeline
- Overview
- Immuno-Oncology Candidates
  - NK100
  - FT500
  - FT516
  - FT596
  - FT538
  - FT819
- Immuno-Regulation Candidates
  - ProTmune^™
  - FT301
Science
Collaborations
Join Our Team
Investors
Contact